Evidence map›Paper›PMID 40762490›Full record

ArticleMicrobiology spectrum2025

Emergence of a piliated and multidrug-resistant

Haruko Miyazaki, Satoshi Nakano, Rie Shibuya, Bin Chang, Yoshitsugu Miyazaki, Tetsuya Matsumoto, Yukihiro Akeda

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Haruko Miyazaki *Department of Microbiology, Tokyo Medical University, Tokyo, Japan.ORCID 0000-0001-8716-8401
Satoshi Nakano *Antimicrobial Resistance Research Center Laboratory 7, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0002-8987-0250
Rie ShibuyaDepartment of Clinical Laboratory, Saiseikai Yokohamashi Tobu Hospital, Kanagawa, Japan.
Bin ChangDepartment of Bacteriology 1, National Institute of Infectious Diseases, Tokyo, Japan.
Yoshitsugu MiyazakiPathogen Genomics Center, National Institute of Infectious Diseases, Tokyo, Japan.ORCID 0000-0001-8942-0869
Tetsuya MatsumotoDepartment of Infectious Diseases, International University of Health and Welfare, Chiba, Japan.
Yukihiro AkedaDepartment of Bacteriology 1, National Institute of Infectious Diseases, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, Multiple, BacterialFimbriae, BacterialPneumococcal InfectionsStreptococcus pneumoniaeAnti-Bacterial AgentsHumansJapanMicrobial Sensitivity TestsMultilocus Sequence TypingSerogroupWhole Genome SequencingAnti-Bacterial Agentsantimicrobial resistancebacterial typingserotype 35B-ST156Streptococcus pneumoniaevaccinewhole-genome sequence

Identifiers

PMID40762490
PMCPMC12403612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.